Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95:20211033.

Article  PubMed  Google Scholar 

Kashyap D, Pal D, Sharma R, Garg VK, Goel N, Koundal D, et al. Global increase in breast cancer incidence: risk factors and preventive measures. Biomed Res Int. 2022;2022:9605439.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Yu C, Chen D, Tang Y, Zhu K, Guo R, et al. A prognostic nomogram based on risk assessment for invasive micropapillary carcinoma of the breast after surgery. Cancer Med. 2023;12:8050–62.

Article  PubMed  PubMed Central  Google Scholar 

Chen H, Wu K, Wang M, Wang F, Zhang M, Zhang P. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis. Cancer Med. 2017;6:2775–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Limaïem F, Bouraoui S. Invasive micropapillary carcinoma: a rare and aggressive breast cancer. Pan Afr Med J. 2021;40:29.

PubMed  PubMed Central  Google Scholar 

Li D, Zhong C, Cheng Y, Zhu N, Tan Y, Zhu L, et al. A competing nomogram to predict survival outcomes in invasive micropapillary breast cancer. J Cancer. 2019;10:6801–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang T, Lai M, Wei Y, Zhu H, Zhu C, Guo Y, et al. Nomograms for predicting overall survival and cancer-specific survival in patients with invasive micropapillary carcinoma: Based on the SEER database. Asian J Surg. 2023;46:3734–40.

Article  PubMed  Google Scholar 

Brasó-Maristany F, Paré L, Chic N, Martínez-Sáez O, Pascual T, Mallafré-Larrosa M, et al. Gene expression profiles of breast cancer metastasis according to organ site. Mol Oncol. 2022;16:69–87.

Article  PubMed  Google Scholar 

Rossing M, Østrup O, Majewski WW, Kinalis S, Jensen MB, Knoop A, et al. Molecular subtyping of breast cancer improves identification of both high and low risk patients. Acta Oncol (Stockholm, Sweden). 2018;57:58–66.

Article  CAS  Google Scholar 

Fan Y, Pan X, Yang F, Liu S, Wang Z, Sun J, et al. Preoperative computed tomography radiomics analysis for predicting receptors status and Ki-67 levels in breast cancer. Am J Clin Oncol. 2022;45:526–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lewis GD, Xing Y, Haque W, Patel T, Schwartz MR, Chen AC, et al. The impact of molecular status on survival outcomes for invasive micropapillary carcinoma of the breast. Breast J. 2019;25:1171–6.

Article  CAS  PubMed  Google Scholar 

Zhao Y, Li S, Yan L, Yang Z, Chai N, Qiu P, et al. Nomogram for predicting overall survival in patients with invasive micropapillary carcinoma after breast-conserving surgery: a population-based analysis. Front Surg. 2022;9:1009149.

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Zhang Y, Yin F, Wang X, Yang Z. Survival outcomes after breast-conserving therapy compared with mastectomy for patients with early-stage invasive micropapillary carcinoma of the breast: a SEER population-based study. Front Oncol. 2021;11: 741737.

Article  PubMed  PubMed Central  Google Scholar 

Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8-30.

Article  PubMed  Google Scholar 

Wu SG, Zhang WW, Sun JY, Li FY, Chen YX, He ZY. Postoperative radiotherapy for invasive micropapillary carcinoma of the breast: an analysis of Surveillance, Epidemiology, and End Results database. Cancer Manag Res. 2017;9:453–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Xiao Z, Hu D, Luo H, Yin G, Feng Y, et al. Cancer-specific survival outcome in early-stage young breast cancer: evidence from the SEER database analysis. Front Endocrinol. 2021;12: 811878.

Article  Google Scholar 

van Maaren MC, de Munck L, Strobbe LJA, Sonke GS, Westenend PJ, Smidt ML, et al. Ten-year recurrence rates for breast cancer subtypes in the Netherlands: a large population-based study. Int J Cancer. 2019;144:263–72.

Article  PubMed  Google Scholar 

Valla M, Vatten LJ, Engstrøm MJ, Haugen OA, Akslen LA, Bjørngaard JH, et al. Molecular subtypes of breast cancer: long-term incidence trends and prognostic differences. Cancer Epidemiol Biomark Prev. 2016;25:1625–34.

Article  CAS  Google Scholar 

Yao J, Jin Q, Wang XD, Zhu HJ, Ni QC. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer. Medicine. 2017;96: e7171.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marie L, Braik D, Abdel-Razeq N, Abu-Fares H, Al-Thunaibat A, Abdel-Razeq H. Clinical characteristics, prognostic factors and treatment outcomes of patients with bone-only metastatic breast cancer. Cancer Manag Res. 2022;14:2519–31.

Article  PubMed  PubMed Central  Google Scholar 

Chen PY, Cheng SH, Hung CF, Yu BL, Chen CM. Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer. Springerplus. 2013;2:589.

Article  PubMed  PubMed Central  Google Scholar 

Johansson ALV, Trewin CB, Hjerkind KV, Ellingjord-Dale M, Johannesen TB, Ursin G. Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer. 2019;144:1251–61.

Article  CAS  PubMed  Google Scholar 

Wang X, Xue Y. Analysis of prognostic factors and construction of prognostic models for invasive micropapillary carcinoma of the breast. Comput Math Methods Med. 2022;2022:1072218.

Article  PubMed  PubMed Central  Google Scholar 

Liu QQ, Sun HF, Yang XL, Chen MT, Liu Y, Zhao Y, et al. Survival following radiotherapy in young women with localized early-stage breast cancer according to molecular subtypes. Cancer Med. 2019;8:2840–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Onitilo AA, Engel JM, Stankowski RV, Doi SA. Survival comparisons for breast conserving surgery and mastectomy revisited: community experience and the role of radiation therapy. Clin Med Res. 2015;13:65–73.

Article  PubMed  PubMed Central  Google Scholar 

Yin L, Duan JJ, Bian XW, Yu SC. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res BCR. 2020;22:61.

Article  PubMed  Google Scholar 

Cao L, Niu Y. Triple negative breast cancer: special histological types and emerging therapeutic methods. Cancer Biol Med. 2020;17:293–306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoon GY, Cha JH, Kim HH, Shin HJ, Chae EY, Choi WJ. Comparison of invasive micropapillary and invasive ductal carcinoma of the breast: a matched cohort study. Acta Radiol (Stockholm, Sweden: 1987). 2019;60:1405–13.

Google Scholar 

Saifi O, Chahrour MA, Li Z, Hoballah J, Panoff J, Vallow LA, et al. Is breast conservation superior to mastectomy in early stage triple negative breast cancer? Breast (Edinburgh, Scotland). 2022;62:144–51.

Article  PubMed  Google Scholar